PharmaLex - Drug Safety Professional (0-1 yrs)
- Author a company clinical comment (CCC) for case reports that are Suspected Unexpected Serious Adverse reaction (SUSAR).
- Edit the Periodic Report Comment, if applicable, directly within the Periodic Report Comment field in the Drug Safety database.
Perform the following actions within the Comments field of the GSP Review Workflow step in the Drug Safety database :
- Review and respond to any queries/comments from the Case Owner, which are recorded in the Comment field of the GSP Review Workflow step in the Drug Safety database.
- Detail any requests for changes to the case, including the narrative.
- Detail any follow-up information that is required and not already noted within the Query Manager in the Drug Safety database.